Pain Management - Acute Flashcards
WHO Pain Ladder Tx for Step 1
- mild pain 1-3/10
- non opioid +-/ adjuvants
WHO Pain Ladder Tx for Step 2
- mod pain 4-6/10
- weak opioid and non-opioid +/- adjuvants
WHO Pain Ladder Tx for Step 3
- severe pain 7-10/10
- strong opioid + non-opioid +/- adjuvants
Acetaminophen/Tylenol Indication
-tx of mild to moderate pain
Acetaminophen/Tylenol MOA
- analgesic: inhibit prostaglandin synthesis in CNS
- antipyretic: inhibits hypothalamic heat regulating center
Acetaminophen/Tylenol Usual Dose
325-650 mg q 4-6hr
- max daily dose 4000 mg/day
- max geri daily dose 3000 mg/day
Acetaminophen/Tylenol AEs
- usually well-tolerated
- may cause hepatotoxicity, analgesic nephropathy, anemia, blood dyscrasias, rare skin rxns
Acetaminophen/Tylenol Hepatotoxicity Mechanism
- small amount of APAP metabolized via CYP450 to hepatotoxic metabolite (NAPQI)
- usually glutathione binds NAPQI to allow excretion
- misuse/overdose uses up all the glutathione so NAPQI is not removed from body
NSAIDs MOA
- AAA: analgesic, antipyretic, anti-inflammatory
- NNSAIDs inhibit COX 1 and 2
- PNSAIDs inhibit COX 2 more than COX 1
- COX 2 only inhibits COX 2
NSAID Efficacy
- most NNSAIDs are more effective than ASA or APAP
- some have greater analgesic effect than oral opioid combinations
NSAID AEs (general list)
- GI
- renal, hematologic, CV, hepatic
- CNS: high doses can cause sedation/decreased cognition in older adults
- skin: rare serious reactions like SJS or TEN
GI NSAID Mucosal Damage
-due to direct or topical irritation of gastric epithelium or systemic inhibition of prostaglandin synthesis
High Risk GI Patients (list the risk factors)
- age > 60
- prior PUD or GI bleed
- high dose or more toxic NSAIDs
- concurrent corticosteroid, bisphosphonate, or SSRI use
- anticoagulant use, antiplatelet use (ASA, clopidogrel)
- chronic illness (eg CV dz)
What NSAID is the least GI toxic? Which is most?
- least celecoxib then ibuprofen
- most is ketorolac
NSAID Nephrotoxicity
- NSAIDs decrease renal blood flow
- interstitial nephritis, hyperkalemia, hyponatremia also reported
(toxicity is related to NSAID effects on renal prostaglandins that help increase renal blood flow)
Risk Factors for NSAID Nephrotoxicity
- older age, HF, renal insufficiency
- ascites, volume depletion, diuretic therapy
(basically anything that also will decrease renal blood flow)
Hematologic NSAID Toxicity
- may prolong bleeding times due to anti-platelet effects
- ASA inhibits platelet aggregation for platelet lifetime (7-10 days)
- other NNSAIDs affect platelet aggregation to a lesser degree and only when drug is active in body
- do not affect INR
Cardiovascular NSAID Toxicity
- may increase CV risk
- risk increases w/ higher dose, longer duration, and degree of COX-2 selectivity
- NSAIDs may increase BP
- avoid NSAIDs after MI indefinitely
NSAID Hepatotoxicity
- no clear link between chemical structure and risk
- histologic type of injury varies within/between chemical classes
- no consistent MOI of liver from NSAIDs
Aspirin Indication
- mild to moderate pain
- prevention of MI, CVA
Aspirin MOA
- analgesic: same as N-NSAIDs
- antipyretic: inhibition of hypothalamic heat regulating center
Aspirin Usual Dose
325-650 mg q4 hours (max dose 5400 mg/day)
Aspirin AEs
- platelet inhibition for life of platelet
- ASA sensitivity (asthma, bronchospasm, angioedema) related to COX1 inhibition
- Reye’s syndrome (esp kids with influenza or varicella)
AEs Nonacetylated (Salsalate, trisalicylate)
- likely less GI toxicity than N-NSAIDs
- no anti-platelet effects
- occasional cross reactivity in ASA sensitive pts
What Med Should a Low GI/Low CV Risk Pt Get
-ibuprofen or other low GI risk NSAID (celecoxib)
What Med Should a Moderate GI/Low CV Risk Pt Get
- celecoxib alone
- NSAID + PPI or misoprostol
- NSAID + double dose H2 blocker